National trends in the epidemiology of prostate cancer, 1973 to 1994: Evidence for the effectiveness of prostate-specific antigen screening

Urology

Volumn 52, Issue 3, 1998, Pages 444-448

  Farkas, A ^a   Schneider, D ^a   Perrotti, M ^a   Cummings, K B ^a   Ward, W S ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN DETECTION; ARTICLE; CANCER GRADING; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0032167503     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00242-8     Document Type: Article

References (23)

1. 1. Anonymous: Review of current data impacting early detection guidelines for prostate cancer. Proceedings of an American Cancer Society workshop. Phoenix, Arizona, March 10-11, 1997. Cancer 80: 1808-1881, 1997.
2. 2. Mettlin C, Jones G, Averette H, et al: Denning and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers (see comments). CA Cancer J Clin 43: 42-46, 1993.
3. 3. von Eschenbach A, Ho R, Murphy GP, et al: American Cancer Society guidelines for the early detection of prostate cancer: update, June 10, 1997. Cancer 80: 1805-1807, 1997.
4. 4. Anonymous: Screening for prostate cancer. American College of Physicians (see comments). Ann Intern Med 126: 480-484, 1997.
5. 5. Brawley OW: Prostate carcinoma incidence and patient mortality: the effects of screening and early detection. Cancer 80: 1857-1863, 1997.
6. 6. Collins MM, and Barry MJ: Controversies in prostate cancer screening: analogies to the early lung cancer screening debate. J Am Med Assoc 276: 1976-1979, 1996.
7. 7. Gann PH: Interpreting recent trends in prostate cancer incidence and mortality (editorial comment). Epidemiology 8: 117-120, 1997.
8. 8. Lancet: The prostate question, unanswered still. Lancet 349: 443, 1997.
9. 9. Surveillance, Epidemiology, and End Results (SEER) Program public use CD-ROM (1973-1994) (program). Bethesda, National Cancer Institute, 1997.
10. 10. Parker SL, Tong T, Bolden S, et al: Cancer statistics, 1997. CA Cancer J Clin 47: 5-27, 1997.
11. 11. Demers RY: Prostate cancer trends in southeast Michigan 1973-1992. In Vivo 8: 429-431, 1994.
12. 12. Demers RY, Swanson GM, Weiss LK, et al: Increasing incidence of cancer of the prostate: the experience of black and white men in the Detroit metropolitan area. Arch Intern Med 154: 1211-1216, 1994.
13. 13. Gilliland F, Becker TM, Smith A, et al: Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening. Cancer Epidemiol Biomark Prev 3: 105-111, 1994.
14. 14. Gilliland FD, Becker TM, Key CR, et al: Contrasting trends of prostate cancer incidence and mortality in New Mexico's Hispanics, non-Hispanic whites, American Indians, and blacks. Cancer 73: 2192-2199, 1994.
15. 15. Gilliland FD, Welsh DJ, Hoffman RM, et al: Rapid rise and subsequent decline in prostate cancer incidence rates for New Mexico, 1989-1993. Cancer Epidemiol Biomark Prev 4: 797-800, 1995.
16. 16. Jacobsen SJ, Katusic SK, Bergstralh EJ, et al: Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing (see comments). J Am Med Assoc 274: 1445-1449, 1995.
17. 17. Newcomer LM, Stanford JL, Blumenstein BA, et al: Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994. J Urol 158: 1427-1430, 1997.
18. 18. Polednak AP: Trends in cancer incidence in Connecticut. Conn Med 61: 211-218, 1997.
19. 19. Polednak AP: Trends in prostate carcinoma incidence in Connecticut (1988-1994) by age and race. Cancer 79: 99-103, 1997.
20. 20. Potosky AL, Miller BA, Albertsen PC, et al: The role of increasing detection in the rising incidence of prostate cancer. J Am Med Assoc 273: 548-552, 1995.
21. 21. Stephenson RA, Smart CR, Mineau GP, et al: The fall in incidence of prostate carcinoma: on the down side of a prostate specific antigen induced peak in incidence - data from the Utah Cancer Registry (see comments). Cancer 77: 1342-1348, 1996.
22. 22. Fritz AG, and Roffers SD: Classification and staging of cancer. Gaithersburg, Maryland, National Cancer Institute.
23. 23. Schwartz KL, Kau TY, Severson RK, et al: Prostate-specific antigen in a community screening program. J Fam Pract 41: 163-168, 1995.